来自粉,类抗氧化剂和盐的具有抗瘤活性的水溶性合物
V V Spiridonov1, M A Torlopov2, I Yu Chukicheva2
1Department of Chemistry, Lomonosov Moscow State University, Leninskie gory 1-3, 119991, Moscow, Russia.
Carbohydrate research
|December 25, 2025
概括
研究人员开发了与抗氧化剂Dibornol结合的新型粉结合物. 该Ca2+-联体对MCF7瘤细胞表现出显著的抗瘤活性,这表明新的抗癌药物设计的潜力.
科学领域:
- 生物材料科学 生物材料科学
- 药用化学 医学化学
- 细胞生物学 细胞生物学
背景情况:
- 基于粉的材料提供生物相容性和生物降解性.
- 类抗氧化剂具有潜在的治疗性质.
- 阴离子结合可以增强药物输送和疗效.
研究的目的:
- 为了合成和表征新的粉-迪博诺合物.
- 为了研究生物基离子结合 (Ca2+,Mg2+) 对这些结合物的作用.
- 评估开发的结合物对MCF7细胞的抗瘤活性.
主要方法:
- 合成电子中性和正性粉与共连接的Dibornol.
- 在水中溶解并与 (Ca2+) 和 (Mg2+) 离子结合.
- 在体外评估对MCF7瘤细胞的细胞毒性.
主要成果:
- 成功合成了粉-迪博诺合物.
- 阳性粉-迪博结合物,当与Ca2+-结合时,对MCF7细胞表现出显著的细胞毒性.
- Mg2+-联并没有表现出明显的活性.
结论:
- 粉-二博结合物可以有效地设计和合成.
- 阴离子结合,特别是与Ca2+,可以赋予强大的抗瘤特性.
- 这种方法为开发新型抗癌配方提供了一个有希望的策略.
相关概念视频
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Factors Affecting Solubility
36.5K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
36.5K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
174
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
174


